Gentherm Earnings Call Transcripts
Fiscal Year 2026
-
The company is accelerating diversification through the Modine acquisition, expanding into commercial, power generation, and adjacent markets while maintaining strong growth in automotive and medical segments. Organizational realignment and operational initiatives support margin expansion, with a clear path to $3.5 billion+ revenue and $520 million+ EBITDA by 2030.
-
The meeting covered director elections, executive compensation, auditor ratification, and an equity plan amendment, all of which were approved. Strategic updates highlighted record revenue, new market expansion, and a major acquisition to drive future growth.
-
Record Q1 revenue and margin expansion were driven by strong automotive and China growth, with new business wins and diversification into home, office, and medical markets. Despite $20M in inflationary headwinds, guidance is maintained, and the Modine merger is on track.
-
The merger nearly doubles revenue, diversifies end markets, and is expected to deliver $25 million in annual cost synergies by 2028. The deal, valued at $1 billion, will be tax-free for Modine shareholders and aims to accelerate growth in commercial, heavy-duty, and power generation markets.
Fiscal Year 2025
-
Record 2025 revenue of $1.5B was driven by strong automotive and adjacent market growth, with margin expansion expected as footprint realignment and new product launches take effect. The planned Modine merger is set to accelerate diversification and scale, with 2026 revenue guidance of $1.5B-$1.6B and further growth projected for 2027.
-
Management outlined a strategy to diversify revenue, drive operational excellence, and expand into high-margin adjacent markets, including medical and furniture, while maintaining strong financial discipline. Facility consolidation and innovation in core products are expected to support margin expansion and growth.
-
Record Q3 revenue and strong cash flow were driven by new business wins, especially with Mercedes-Benz and GM, and robust demand in automotive and adjacent markets. Full-year guidance was raised, with ongoing supply chain risks being closely monitored.
-
Management is executing a strategy to scale core technologies into new markets, drive operational excellence, and diversify revenue beyond automotive. Financial targets include mid-teens EBITDA, improved cash conversion, and significant growth in medical and adjacent markets.
-
Q2 results met expectations with improved EBITDA margin and strong new business awards, including a major Ford F-Series win. Revenue guidance was raised, EBITDA margin guidance narrowed, and capital expenditures reduced. Adjacent market expansion and a shift toward Chinese domestic OEMs are progressing.
-
Leadership outlined a strategy to scale core technologies across automotive, medical, and adjacent markets, supported by operational standardization and cost optimization. Innovation and portfolio focus drive growth, with strong prospects in climate-controlled seating, pneumatic comfort, and China.
-
Q1 results met expectations with $400M in new business awards and strong progress in both automotive and medical segments. Revenue guidance was maintained despite a weaker industry outlook, with margin guidance lowered due to volume and tariff impacts.
Fiscal Year 2024
-
Fourth-quarter revenue declined 3.8% year-over-year, but core automotive and medical segments showed growth. 2025 guidance anticipates 2% revenue growth (ex-FX), 12–13% EBITDA margin, and continued margin expansion after a 30% footprint reduction.
-
The company is executing a focused growth strategy, securing over $2 billion in new business awards for 2024 and expanding margins through innovation and cost management. Leadership transition is planned and stable, with strong momentum in product launches and market expansion, especially in China and mass-market vehicles.
-
Secured $1.8B in new awards YTD and outperformed auto production by 800 bps, but lowered 2024 revenue guidance to $1.45–$1.47B due to market declines. Adjusted EBITDA margin expected near midpoint of 12.5%–13.5%, with strong innovation and share repurchases continuing.
-
Leadership highlighted strong growth in thermal and pneumatic comfort solutions, record new business awards, and innovation in integrated hardware and software platforms. Expansion in Asia, selective partnerships with Chinese OEMs, and scalable product offerings position the company for continued growth.
-
Record quarterly revenue and strong new business awards were achieved despite a challenging automotive environment. Profitability improved with a 13.3% adjusted EBITDA margin, and guidance was reaffirmed for organic growth and margin expansion, supported by new launches and innovation.
-
Strong innovation and focused execution are driving rapid growth in thermal and pneumatic comfort solutions, with significant new business wins, especially in China and with major OEMs. Cost-saving initiatives and new product launches support robust financial outlook and margin expansion.